CureVac
The Latest
-
German Health Minister Expects To Have COVID-19 Vaccine By Early Next Year
Germany's infection cases have been on the rise in the past weeks. 
Germany's infection cases have been on the rise in the past weeks. -
BioNTech, CureVac Vaccine Testing Gets Boost With $745 Million Germany Government Funding
Germany’s Research Minister Anja Karliczek says safety is the best way to guarantee vaccines get approval and be accepted by citizens. 
Germany’s Research Minister Anja Karliczek says safety is the best way to guarantee vaccines get approval and be accepted by citizens. -
CureVac Inches Closer To Supplying EU With 405 Million COVID Vaccines
Shares of CureVac rose 16 percent and closed at $66 on Thursday following news of the supply deal. 
Shares of CureVac rose 16 percent and closed at $66 on Thursday following news of the supply deal. -
Germany's CureVac Seeks To Secure $245 Million In U.S. IPO
Results of CureVac's third-stage clinical trial for a COVID-19 vaccine will be released in the fourth quarter this year. 
Results of CureVac's third-stage clinical trial for a COVID-19 vaccine will be released in the fourth quarter this year. -
Germany Acquires 23% Stake Worth $337 Million In Biotech Firm CureVac
Germany preps to push on with work for its mRNA vaccine against the COVID-19 pandemic. 
Germany preps to push on with work for its mRNA vaccine against the COVID-19 pandemic.
